Key result
In a simulated heart failure condition, a /kg/min sodium nitroprusside infusion during LVAD assistance (24000 rpm) reduced mean arterial pressure by ~9% and increased cardiac output by ~12%.
Why the study?
Does sodium nitroprusside combined with LVAD assistance improve hemodynamic parameters in a cardiovascular circulatory model?
Does sodium nitroprusside combined with LVAD assistance improve hemodynamic parameters in a cardiovascular circulatory model?
Answers are grounded in this paper and cite their sources.
A numerical model demonstrates that sodium nitroprusside infusion combined with LVAD assistance significantly alters hemodynamic parameters, providing a tool to support clinical decision-making in heart failure.
The aim of this work is to develop a tool to study the effect of sodium nitroprusside (SNP) on hemodynamics in conjunction with baroreflex and mechanical circulatory assistance. To this aim, a numerical model of the pharmacodynamic effect of SNP was developed and inserted into a cardiovascular circulatory model integrated with baroreflex and LVAD (continuous flow pump with atrio-aortic connection) sub-models.The experiments were carried out in two steps. In the first step the model was verified comparing simulations with experimental data acquired from mongrel dogs on mean arterial pressure (MAP), cardiac output (CO), heart rate (HR), peripheral resistance, and left ventricular properties.In the second step, the combined action of SNP and mechanical circulatory assistance was studied. Data were measured at pump off and at pump on (20000 rpm and 24000 rpm). At pump off, with a 2.5 µg/kg per min SNP infusion in heart failure condition, the MAP was reduced by approximately 8%, CO and HR increased by about 16% and 18%, respectively. In contrast, during assistance (24000 rpm) the changes in MAP, CO and HR were around -9%, +12%, and +20%, respectively. Furthermore, the effects of the drug on hemodynamic parameters at different heart conditions were significantly different. Thus, the model provides insight into the complex interactions between baroreflex, drug infusion, and LVAD and could be a support for clinical decision-making in cardiovascular pathologies.
No takes yet. Share an insight, caveat, or question.
Mahmood et al. (2014) studied Heart failure. Sodium nitroprusside (SNP) and LVAD assistance vs. Pump off vs Pump on was evaluated on Hemodynamic parameters (MAP, CO, HR). In a simulated heart failure condition, a /kg/min sodium nitroprusside infusion during LVAD assistance (24000 rpm) reduced mean arterial pressure by ~9% and increased cardiac output by ~12%.
Synapse has enriched 10 related papers. Consider them for comparative context: